Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) Cash from Investing Activities (2018 - 2025)

Arcturus Therapeutics Holdings' Cash from Investing Activities history spans 8 years, with the latest figure at $88000.0 for Q4 2025.

  • For Q4 2025, Cash from Investing Activities changed N/A year-over-year to $88000.0; the TTM value through Dec 2025 reached -$230000.0, up 64.51%, while the annual FY2025 figure was -$230000.0, 64.51% up from the prior year.
  • Cash from Investing Activities reached $88000.0 in Q4 2025 per ARCT's latest filing, up from -$181000.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $378000.0 in Q2 2022 to a low of -$3.8 million in Q4 2022.
  • Average Cash from Investing Activities over 5 years is -$828388.9, with a median of -$379000.0 recorded in 2021.
  • The largest YoY upside for Cash from Investing Activities was 193.56% in 2022 against a maximum downside of 1688.98% in 2022.
  • A 5-year view of Cash from Investing Activities shows it stood at -$1.1 million in 2021, then tumbled by 240.52% to -$3.8 million in 2022, then soared by 77.02% to -$875000.0 in 2023, then surged by 90.86% to -$80000.0 in 2024, then surged by 210.0% to $88000.0 in 2025.
  • Per Business Quant, the three most recent readings for ARCT's Cash from Investing Activities are $88000.0 (Q4 2025), -$181000.0 (Q3 2025), and -$137000.0 (Q1 2025).